On Monday, Johnson & Johnson (NYSE: JNJ) opened higher 0.19% from the last session, before settling in for the closing price of $149.31. Price fluctuations for JNJ have ranged from $143.13 to $168.85 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 1.31% over the past five years. Company’s average yearly earnings per share was noted 0.32% at the time writing. With a float of $2.40 billion, this company’s outstanding shares have now reached $2.41 billion.
Let’s look at the performance matrix of the company that is accounted for 131900 employees. In terms of profitability, gross margin is 69.05%, operating margin of 25.22%, and the pretax margin is 20.1%.
Johnson & Johnson (JNJ) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of Johnson & Johnson is 0.12%, while institutional ownership is 72.76%. The most recent insider transaction that took place on Dec 04 ’24, was worth 3,858,598. Before that another transaction happened on Aug 30 ’24, when Company’s VP Corporate Controller sold 5,635 for $165.06, making the entire transaction worth $930,113. This insider now owns 18,973 shares in total.
Johnson & Johnson (JNJ) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.66 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.32% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.00% during the next five years compared to -0.27% drop over the previous five years of trading.
Johnson & Johnson (NYSE: JNJ) Trading Performance Indicators
Check out the current performance indicators for Johnson & Johnson (JNJ). In the past quarter, the stock posted a quick ratio of 0.79. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.10. Likewise, its price to free cash flow for the trailing twelve months is 17.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 6.05, a number that is poised to hit 2.02 in the next quarter and is forecasted to reach 10.58 in one year’s time.
Technical Analysis of Johnson & Johnson (JNJ)
Johnson & Johnson (NYSE: JNJ) saw its 5-day average volume 8.74 million, a positive change from its year-to-date volume of 7.09 million. As of the previous 9 days, the stock’s Stochastic %D was 10.84%. Additionally, its Average True Range was 2.23.
During the past 100 days, Johnson & Johnson’s (JNJ) raw stochastic average was set at 5.96%, which indicates a significant decrease from 13.97% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 12.42% in the past 14 days, which was lower than the 14.75% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $157.96, while its 200-day Moving Average is $155.58. Nevertheless, the first resistance level for the watch stands at $150.85 in the near term. At $152.09, the stock is likely to face the second major resistance level. The third major resistance level sits at $153.30. If the price goes on to break the first support level at $148.40, it is likely to go to the next support level at $147.19. The third support level lies at $145.95 if the price breaches the second support level.
Johnson & Johnson (NYSE: JNJ) Key Stats
There are currently 2,407,623K shares outstanding in the company with a market cap of 359.67 billion. Presently, the company’s annual sales total 85,159 M according to its annual income of 35,153 M. Last quarter, the company’s sales amounted to 22,471 M and its income totaled 2,694 M.
